Page last updated: 2024-11-03

ag 1879 and Alloxan Diabetes

ag 1879 has been researched along with Alloxan Diabetes in 2 studies

3-(4-chlorophenyl)-1-(1,1-dimethylethyl)-1H-pyrazolo(3,4-d)pyrimidin-4-amine: Fyn kinase inhibitor

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Taniguchi, K1
Xia, L1
Goldberg, HJ1
Lee, KW1
Shah, A1
Stavar, L1
Masson, EA1
Momen, A1
Shikatani, EA1
John, R1
Husain, M1
Fantus, IG1
Mima, A1
Matsubara, T1
Arai, H1
Abe, H1
Nagai, K1
Kanamori, H1
Sumi, E1
Takahashi, T1
Iehara, N1
Fukatsu, A1
Kita, T1
Doi, T1

Other Studies

2 other studies available for ag 1879 and Alloxan Diabetes

ArticleYear
Inhibition of Src kinase blocks high glucose-induced EGFR transactivation and collagen synthesis in mesangial cells and prevents diabetic nephropathy in mice.
    Diabetes, 2013, Volume: 62, Issue:11

    Topics: ADAM Proteins; ADAM17 Protein; Albuminuria; Animals; Collagen Type IV; Diabetes Mellitus, Experiment

2013
Angiotensin II-dependent Src and Smad1 signaling pathway is crucial for the development of diabetic nephropathy.
    Laboratory investigation; a journal of technical methods and pathology, 2006, Volume: 86, Issue:9

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Butadienes; Cell Line; Collagen Ty

2006